Oyster mushroom

DIETARY_SUPPLEMENT3 trials

Sponsors

National Center for Complementary and Integrative Health (NCCIH), Wake Network, Inc., University of Reading

Conditions

Anxiety and DepressionCognitive ChangeHIV InfectionsHyperlipidemiaInflammatory ResponseMetabolismMoodWeight Change

Phase 1

Antihyperlipidemic Effects of Oyster Mushrooms

CompletedNCT00069524

National Center for Complementary and Integrative Health (NCCIH)HIV Infections, Hyperlipidemia

Start: 2004-06-30End: 2006-05-31Target: 20Updated: 2007-09-26

Phase 2

Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults

WithdrawnNCT04989972

Wake Network, Inc.Anxiety and Depression

Start: 2022-09-15End: 2023-08-31Updated: 2022-06-30

Unknown Phase

Cognitive, Mood, Anti-Inflammatory and Metabolic Effects of Chronic Oyster Mushroom Intervention in Older Adults

CompletedNCT06846827

University of ReadingCognitive Change, Inflammatory Response, Metabolism +2

Start: 2023-10-01End: 2024-07-03Updated: 2025-03-04